Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T13:36:28.947Z.
Calculation as of: 2026-10-06T13:36:28.947Z.
Quote observation: 2026-10-06T13:30:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$3.42M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.12M
PS Ratio
N/A
TTM Avg
71.18
3Y Avg
73.71
5Y Avg
73.71
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.78M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.53M | 2.70 | 2.12 | 1.98 | 176.94 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.13M | N/A | 1.94 | 5.55 | 4.76 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | N/A | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.38M | 0.86 | 8.88 | 13.52 | 16.08 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | N/A | 69.25 | 700.44 | 2108.35 |
| GRI Bio, Inc. (GRI)vs › | $4.36M | N/A | 66865.41 | 66865.41 | 66865.41 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.42M | 2.17 | 2.70 | 2.70 | 2.70 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.12M | N/A | 71.18 | 73.71 | 73.71 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.49M | N/A | 2863.91 | 2004.87 | 2004.87 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
